- The Wall Street Journal•6 days ago
Venture-backed biopharmaceutical company Molecular Templates Inc. is merging with a subsidiary of publicly traded Threshold Pharmaceuticals Inc.
- Investopedia•10 days ago
Threshold will merge with Molecular Templates to form a new public cancer-focused company.
- GlobeNewswire•10 days ago
--Transaction to result in Nasdaq-listed company focused on developing novel treatments for cancer--. --Molecular Templates lead drug candidate being developed to treat non-Hodgkin’ s Lymphoma; engineered ...
THLD : Summary for Threshold Pharmaceuticals, Inc. - Yahoo Finance
Threshold Pharmaceuticals, Inc. (THLD)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Day's Range||0.52 - 0.61|
|52 Week Range||0.30 - 1.48|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||0.94|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|